MedTrace Logo

Hypotension Prediction Index (HPI) in Patients Undergoing Robotic Assisted Radical Prostatectomy

NCT06535464 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-08-02

No results posted yet for this study

Summary

Robot assisted radical prostatectomy (RARP) is the leader in robotic treatment for prostate cancer. Goal-directed therapy (GDT) is the approach used, but HPI, a machine learning algorithm analysing arterial waveforms, might offer additional benefits. The aim of this prospective randomised study is to evaluate the cumulative amount of intraoperative arterial hypotension episodes in patients undergoing RARP managed by GDT protocol guided or not by HPI algorithm

Conditions

  • Hypotension During Surgery

Interventions

DEVICE

Hypotension Prediction Index

Fluid management guided by Hypotension Prediction Index

DEVICE

No Hypotension Prediction Index

Fluid management not guided by Hypotension Prediction Index

Sponsors & Collaborators

  • University of Foggia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-04-30
Completion
2023-09-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06535464 on ClinicalTrials.gov